Global Genomics In Cancer Care Market
Food And Beverages

Insights Into The Genomics In Cancer Care Market’s Growth Potential 2024-2033

The Business Research Company’s global market reports are now updated with the latest market sizing information for the year 2024 and forecasted to 2033

 

The genomics in cancer care market has witnessed rapid growth, with a projected increase from $15.08 billion in 2023 to $17.79 billion in 2024, representing a compound annual growth rate (CAGR) of 18.0%. This growth is driven by advancements in data analytics, increasing prevalence of cancer, and a focus on genomic data privacy and security. By 2028, the market is expected to reach $33.28 billion, with a CAGR of 17.0%.

 

Boosting Market Growth Through Funding and Investments in Cancer Research
The market is experiencing growth due to increased funding and investments in genomics research for cancer. Governments and organizations worldwide are investing heavily in innovative genomics technologies, such as next-generation sequencing platforms and liquid biopsy assays. For example, the UK government has invested £175 million ($1.2 million) to advance genomics research, aiming to deliver world-leading genomic healthcare to patients.

 

Get A Free Sample On The Global Genomics In Cancer Care Market Report:
https://www.thebusinessresearchcompany.com/sample_request?id=8159&type=smp

 

Advancements in Next-Generation Sequencing Technologies
Technological advancements, particularly in next-generation sequencing (NGS) technologies, are transforming genomics in cancer care. Companies like Personalis, Inc. are developing innovative liquid biopsy assays, such as NeXT Personal, which offer industry-leading sensitivity in detecting residual molecular disease (MRD) and cancer recurrence. These technologies are revolutionizing cancer diagnostics and personalized medicine.

 

Agilent Technologies Inc. Expands Cancer Diagnostics Portfolio
In a strategic move, Agilent Technologies Inc. acquired Resolution Bioscience Inc. for $550 million in March 2021. This acquisition enhances Agilent’s NGS-based cancer diagnostics portfolio, enabling the development of innovative technologies for precision medicine. Resolution Bioscience Inc. specializes in precision oncology technologies based on NGS, particularly in non-invasive liquid biopsy assays.

 

The Future of Genomics in Cancer Care
The genomics in cancer care market is segmented by product type, technology, application, and end-user, reflecting the diverse applications of genomics in cancer treatment. With North America leading the market in 2023 and Asia-Pacific expected to be the fastest-growing region, the future of genomics in cancer care looks promising, with advancements in personalized medicine and reduced costs of genomic sequencing driving market growth.

 

Read The Full Genomics In Cancer Care Market Report Here:
https://www.thebusinessresearchcompany.com/report/genomics-in-cancer-care-global-market-report

 

The Genomics In Cancer Care Global Market Report 2024  provides an overview of the genomics in cancer care market for the time series: historic years (2010 – 2021) and ten years forecast (2023 – 2032). The genomics in cancer care market forecast analyzes genomics in cancer care market size, genomics in cancer care market share, leading competitor and their market positions.

 

The Table Of Content For The Genomics In Cancer Care Market Include:
1. Genomics In Cancer Care Market Executive Summary
2. Genomics In Cancer Care Market Segments
3. Genomics In Cancer Care Market Size And Genomics In Cancer Care Market Growth Rate
4. Key Genomics In Cancer Care Market Trends
5. Major Genomics In Cancer Care Market Drivers
……
25. Key Mergers And Acquisitions In The Genomics In Cancer Care Market
26. Top Genomics In Cancer Care Companies
27. Genomics In Cancer Care Market Opportunities And Strategies
28. Genomics In Cancer Care Market, Conclusions And Recommendations
29. Appendix

 

Explore Similar Reports From The Business Research Company:
Cancer Biologics Global Market Report 2024
Cancer Diagnostics Global Market Report 2024
Cancer Monoclonal Antibodies Global Market Report 2024

 

Learn More About The Business Research Company
The Business Research Company has published over 6500+ detailed industry reports, spanning over 3000+ market segments and 60 geographies. The reports draw on 1,500,000 datasets, extensive secondary research, and exclusive insights from interviews with industry leaders.

Contact us at:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas
+1 3156230293
Asia +44 2071930708
Europe +44 2071930708
Email us at info@tbrc.info

 

Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model
Found this article helpful? Share it on:

Leave a Reply

Your email address will not be published. Required fields are marked *